Galapagos

Clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines.

HQ location

Mechelen, Belgium

Website

Launch date

1999

Employees

501-1000 people

Market cap

Enterprise value

($1b)

Share price

€28.08 GLPG.VI

Company register number

Recent deals

Frontier Medicines

https://twitter.com/galapagosnv https://www.linkedin.com/company/glpg/

Authorizing premium user...